Estimates Revisions Actinium Pharmaceuticals, Inc.
Stocks
ATNM
US00507W2061
Biotechnology & Medical Research
|
Delayed
NYSE
05:08:26 01/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 1.160 USD | +1.75% |
|
-1.69% | -14.71% |
| 15/08 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 15/08 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- ATNM Stock
- Consensus Actinium Pharmaceuticals, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
